Glaukos Corp- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Glaukos Corp 公司

Glaukos Corporation 是一家眼科药物和医疗技术公司。该公司开发新型无滴疗法，并将相关产品商业化，用于治疗青光眼、角膜疾病和视网膜疾病。其候选产品包括微创青光眼手术产品，该产品涉及插入微型装置，旨在通过恢复青光眼患者的自然房水流出途径来降低眼压 (IOP)，以及基于前房内药物输送技术的程序性药物，旨在通过长时间从眼内输送治疗水平的青光眼药物来降低眼压。其产品包括应用于眼睑的透皮药物，旨在治疗青光眼、干眼症、老花眼和其他眼表疾病和障碍，以及微创、生物可侵蚀的缓释药物输送植入物，以改善患者的视力。

Glaukos Corp简介



公司代码GKOS

公司名称Glaukos Corp

上市日期Jun 25, 2015

CEOMr. Thomas William Burns

员工数量995

证券类型Ordinary Share

年结日Jun 25

公司地址1 Glaukos Way

城市ALISO VIEJO

上市交易所NYSE Consolidated

国家United States of America

邮编92656

电话19493679600

网址https://www.glaukos.com

公司代码GKOS

上市日期Jun 25, 2015

CEOMr. Thomas William Burns

Glaukos Corp公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Thomas William Burns

Chairman of the Board, Chief Executive Officer

1.51M

+0.69%

Mr. David F. Hoffmeister

Independent Director

69.52K

+56.16%

Mr. Mark J. Foley

Lead Independent Director

56.36K

+3.89%

Ms. Aimee S. Weisner, J.D.

Independent Director

49.23K

+4.47%

Mr. Marc A. Stapley

Independent Director

36.18K

+6.19%

Dr. Tomas Navratil

Chief Development Officer

33.32K

-12.37%

Dr. Leana S. Wen, M.D.

Independent Director

--

Dr. Gilbert H. (Gil) Kliman, M.D.

Independent Director

--

Ms. Denice M. Torres, J.D.

Independent Director

--

Mr. Joseph E. Gilliam

President, Chief Operating Officer

--

名称

名称/职务

职务

持股

持股变动

Mr. Thomas William Burns

Chairman of the Board, Chief Executive Officer

1.51M

+0.69%

Mr. David F. Hoffmeister

Independent Director

69.52K

+56.16%

Mr. Mark J. Foley

Lead Independent Director

56.36K

+3.89%

Ms. Aimee S. Weisner, J.D.

Independent Director

49.23K

+4.47%

Mr. Marc A. Stapley

Independent Director

36.18K

+6.19%

Dr. Tomas Navratil

Chief Development Officer

33.32K

-12.37%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

业务USD

名称

营收

占比

Glaucoma

103.53M

83.41%

Corneal Health

20.59M

16.59%

地区USD

名称

营收

占比

United States

90.52M

72.93%

International

33.60M

27.07%

业务

地区

业务USD

名称

营收

占比

Glaucoma

103.53M

83.41%

Corneal Health

20.59M

16.59%

股东统计

更新时间: 8月16日周六

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.75%

The Vanguard Group, Inc.

10.50%

Fidelity Management & Research Company LLC

9.12%

Wellington Management Company, LLP

5.65%

State Street Investment Management (US)

3.64%

其他

57.34%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.75%

The Vanguard Group, Inc.

10.50%

Fidelity Management & Research Company LLC

9.12%

Wellington Management Company, LLP

5.65%

State Street Investment Management (US)

3.64%

其他

57.34%

股东类型

持股股东

占比

Investment Advisor

56.75%

Investment Advisor/Hedge Fund

34.75%

Hedge Fund

9.08%

Individual Investor

3.32%

Pension Fund

2.06%

Research Firm

1.76%

Sovereign Wealth Fund

1.32%

Bank and Trust

1.12%

Family Office

0.04%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

653

61.34M

106.80%

+235.97K

2025Q2

638

61.06M

106.48%

+15.37K

2025Q1

643

60.20M

105.40%

-1.30M

2024Q4

610

59.75M

105.65%

+533.86K

2024Q3

567

57.47M

104.31%

-894.95K

2024Q2

545

56.86M

103.79%

-713.22K

2024Q1

509

54.47M

110.12%

-1.91M

2023Q4

480

53.71M

109.34%

-1.79M

2023Q3

475

52.90M

108.58%

-1.85M

2023Q2

486

51.69M

106.83%

-2.99M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

7.90M

13.77%

+252.68K

+3.31%

Jun 30, 2025

The Vanguard Group, Inc.

6.10M

10.63%

+146.00K

+2.45%

Jun 30, 2025

Fidelity Management & Research Company LLC

5.24M

9.14%

-327.70K

-5.89%

Jun 30, 2025

Wellington Management Company, LLP

3.24M

5.66%

+953.61K

+41.63%

Jun 30, 2025

State Street Investment Management (US)

2.09M

3.64%

+105.97K

+5.34%

Jun 30, 2025

PRIMECAP Management Company

1.83M

3.19%

+609.52K

+50.02%

Jun 30, 2025

Burns (Thomas William)

1.51M

2.63%

+10.26K

+0.69%

Sep 23, 2025

Geode Capital Management, L.L.C.

1.33M

2.32%

+115.53K

+9.51%

Jun 30, 2025

AllianceBernstein L.P.

1.25M

2.18%

-25.68K

-2.01%

Jun 30, 2025

Westfield Capital Management Company, L.P.

1.17M

2.04%

+83.67K

+7.72%

Jun 30, 2025

持股ETF



更新时间: 11月6日周四

机构名称

占比

Invesco S&P SmallCap Health Care ETF

2.97%

Alger Weatherbie Enduring Growth ETF

1.88%

SPDR S&P Health Care Equipment ETF

1.53%

ROBO Global Healthcare Technology & Innovation ETF

1.31%

Vanguard S&P Small-Cap 600 Growth Index Fund

0.63%

SPDR S&P 600 Small Cap Growth ETF

0.63%

iShares S&P Small-Cap 600 Growth ETF

0.59%

iShares U.S. Medical Devices ETF

0.57%

SPDR S&P SmallCap 600 ESG ETF

0.46%

OneAscent Small Cap Core ETF

0.46%

Invesco S&P SmallCap Health Care ETF

占比2.97%

Alger Weatherbie Enduring Growth ETF

占比1.88%

SPDR S&P Health Care Equipment ETF

占比1.53%

ROBO Global Healthcare Technology & Innovation ETF

占比1.31%

Vanguard S&P Small-Cap 600 Growth Index Fund

占比0.63%

SPDR S&P 600 Small Cap Growth ETF

占比0.63%

iShares S&P Small-Cap 600 Growth ETF

占比0.59%

iShares U.S. Medical Devices ETF

占比0.57%

SPDR S&P SmallCap 600 ESG ETF

占比0.46%

OneAscent Small Cap Core ETF

占比0.46%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据